Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.

Biomarkers in medicine - 1 Dec 2024

Wang Han, Ma Junrui, Lu Jiagui, Wang Yang, Zhang Binli, Zhang Hushan, Peng Hao

Abstract excerpt

AIMS: Study on the prognostic characteristics and biomarkers of lung cancer in Xuanwei Patients. MATERIALS AND METHODS: A retrospective analysis was conducted on the genetic data of 261 NSCLC patients, as well as the prognostic data of 133 patients. The relationship between prognosis and EGFR mutations in the Xuanwei and non Xuanwei cohorts was compared and analyzed. RESULTS: The superior progression-free...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 39633593
DOI: 10.1080/17520363.2024.2432306
PMCID: PMC11654810

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.PMID 39633593Read ↗

The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort.Semantic proximity Read ↗

Prognostic value of tumor mutation burden in non-small cell lung cancer: A Meta-Analysis and system reviewSemantic proximity Read ↗

Analysis of gene mutation spectrum and prevention and treatment of lung cancer patients in Qujing, Yunnan Province, ChinaSemantic proximity Read ↗

The prognostic value of tumor mutation burden in EGFR-mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data baseSemantic proximity Read ↗

Prognostic implications of the EGFR polymorphism rs763317 and clinical variables among young Chinese lung cancer population.Semantic proximity Read ↗

Tumor mutational burden and efficacy of chemotherapy in lung cancer.Semantic proximity Read ↗

Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.Semantic proximity Read ↗

Construction and validation of a prognostic nomogram model for SCLC patients in Shandong Province, ChinaSemantic proximity Read ↗

Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.Semantic proximity Read ↗

Correlation between KRAS mutation subtypes and prognosis in Chinese advanced non-squamous non-small cell lung cancer patients.Semantic proximity Read ↗

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.